NCT02872688View on ClinicalTrials.gov

Influence of GanedenBC30 (Bacillus Coagulans GBI-30, 6086) on the Gut Microbiome in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 19, 2016

Study Completion Date

April 13, 2017

Conditions
Healthy Volunteers
Interventions
OTHER

GanedenBC30

Trial Locations (1)

N1G 0B4

Nutrasource Diagnostics Inc., Guelph

All Listed Sponsors
collaborator

Ganeden Biotech, Inc.

INDUSTRY

lead

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

NCT02872688 - Influence of GanedenBC30 (Bacillus Coagulans GBI-30, 6086) on the Gut Microbiome in Healthy Adults | Biotech Hunter | Biotech Hunter